0001485003-16-000050.txt : 20160229
0001485003-16-000050.hdr.sgml : 20160229
20160229171124
ACCESSION NUMBER: 0001485003-16-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160225
FILED AS OF DATE: 20160229
DATE AS OF CHANGE: 20160229
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celniker Abbie
CENTRAL INDEX KEY: 0001590250
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 161469418
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC.
STREET 2: 215 FIRST STREET, SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_145678385663428.xml
FORM 4
X0306
4
2016-02-25
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001590250
Celniker Abbie
C/O ELEVEN BIOTHERAPEUTICS, INC.,
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Stock Option (Right to Buy)
0.28
2016-02-25
4
A
0
113250
0
A
2026-02-24
Common Stock
113250.0
113250
D
Stock Option (Right to Buy)
0.28
2016-02-25
4
A
0
90000
0
A
2026-02-24
Common Stock
90000.0
90000
D
This option was granted February 25, 2016 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2016.
This option was granted on February 25, 2016 and vests over two years in equal monthly installments, with the first installment vesting on March 25, 2016.
/s/ John J. McCabe as attorney-in-fact
2016-02-29